Skip to main content
SpringerLink
Log in

History and Introduction

  • Chapter
Quinolone Antibacterials

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 127))

  • 346 Accesses

Abstract

Lesher et al. (1962) showed that 7-chloro-1,4-dihydro-1-ethyl-4-oxoquinoline-3-carboxylic acid, referred to as compound (a), which was obtained as an impurity during the manufacture of chloroquine, possessed antibacterial activity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albrecht R (1977) Development of antibacterial agents of the nalidixic type. Prog Drug Res 21:9–104

    PubMed  CAS  Google Scholar 

  • Bergan T, Williams JD (1982) Dose-dependence of piperacillin pharmacokinetics. Chemotherapy 28:153–159

    Article  PubMed  CAS  Google Scholar 

  • Bergan T, Thornsteinsson SB, Steingrimsson O (1982) Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin. Chemotherapy 28:160–170

    Article  PubMed  CAS  Google Scholar 

  • Chao L (1978) An unusual interaction between the target of nalidixic acid and novobiocin. Nature 271:385–386

    Article  PubMed  CAS  Google Scholar 

  • Crumplin GC, Smith JT (1975) Nalidixic acid, an antibacterial paradox. Antimicrob Agents Chemother 8:251–261

    PubMed  CAS  Google Scholar 

  • Dalhoff A (1994) Activities of ciprofloxacin and sparfloxacin against strept. pneumoniae (Abstr 34). 5th International Congress on New Quinolones, Singapore, p 43

    Google Scholar 

  • Domagala JM (1994) Structure-activity and structure side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 33:685–706

    Article  PubMed  CAS  Google Scholar 

  • Gerster JF (1973) DOS 2 264 163. Substituted benzo[ij]quinazoline-2-carboxylic acids and their derivatives, Riker Laboratories, Northridge. Chem Abstr 79:92029y

    Google Scholar 

  • Hokuriku Pharmaceutical (Japan) (1986) NY — 198. Drugs Future 11:578–579

    Google Scholar 

  • Holden HE, Barrett JF, Huntington CM, Muehlbauer PA, Wahrenburg MG (1989) Genetic profile of nalidixic acid analog: a model for the mechanism of sister chromatid exchange induction. Environ Mol Mutag 13:238–252

    Article  CAS  Google Scholar 

  • Hooper DC, Wolfson JS (1993) Adverse effects. In: Hooper DC, Wolfson JS (eds) Quinolone antimicrobial agents, 2nd edn. American Society of Microbiology, Washington, pp 489–512

    Google Scholar 

  • Howard BMA, Pinney RJ, Smith JT (1993) 4-quinolone bactericidal mechanisms. Arzneimittelforschung 43:1125–1129

    PubMed  CAS  Google Scholar 

  • Lesher GY, Carabateas PM (1972) DOS 2224090. l-Alkyl-l,4-dihydro-4-oxo-3-quinolonecarboxylic acids and esters

    Google Scholar 

  • Lesher GY, Carabateas PM (1973) l-Alklyl-l,4-dihydro-4-oxo-3-quniolonecarboxylic acids and esters. Sterling Drug Inc. (C.A. 78, 84280 n (1973))

    Google Scholar 

  • Lesher GY, Froelich EJ, Gruett MD, Bailey JH, Brundage RP (1962) 1,8- naphthyridine derivatives, a new class of chemotherapy agents. J Med Chem 5:1063–1065

    Article  CAS  Google Scholar 

  • Lewin CS (1992) Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628. J Med Microbiol 36:353–357

    Article  PubMed  CAS  Google Scholar 

  • Lewin CS, Amyes SGB (1989) The bactericidal activity of DR-3355, an optically active isomer of ofloxacin. J Med Microbiol 30:227–231

    Article  PubMed  CAS  Google Scholar 

  • Lewin CS, Amyes SGB (1990a) Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16. J Med Microbiol 32:83–86

    Article  PubMed  CAS  Google Scholar 

  • Lewin CS, Amyes SGB (1990b) Bactericidal action of PD 127391, an enhanced spectrum quinolone. J Med Microbiol 33:67–70

    Article  PubMed  CAS  Google Scholar 

  • Lewin CS, Smith JT (1988) Bactericidal mechanisms of ofloxacin. J Antimicrob Chemother [Suppl C] 22:1–8

    Article  CAS  Google Scholar 

  • Lewin CS, Smith JT (1989) Interactions of 4-quinolones with other antibacterials. J Med Microbiol 29:221–227

    Article  PubMed  CAS  Google Scholar 

  • Lewin CS, Smith JT (1990) Conditions requried for the bactericidal activity of 4- quinolones against Serratia marcescens. J Med Microbiol 32:211–214

    Article  PubMed  CAS  Google Scholar 

  • Lewin CS, Amyes SGB, Smith JT (1989) Bactericidal activity of enoxacin and lomefloxacin against Escherischia coli K16. Eur J Clin Microbiol 8:731–733

    Article  CAS  Google Scholar 

  • Lewin CS, Howard BMA, Smith JT (1991a) 4-quinolone interactions with gyrase B subunit inhibitors. J Med Microbiol 35:358–362

    Article  PubMed  CAS  Google Scholar 

  • Lewin CS, Morrissey I, Smith JT (1991b) The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment. Eur J Clin Microbiol 10:240–248

    Article  CAS  Google Scholar 

  • Lewin CS, Morrissey I, Smith JT (1991c) The fluoroquinolones exert a reduced rate of kill against Enterococcus faecalis. J Pharm Pharmacol 43:492–494

    Article  PubMed  CAS  Google Scholar 

  • Lewin CS, Howard BMA, Smith JT (1991d) Protein-and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase. J Med Microbiol 34:19–22

    Article  PubMed  CAS  Google Scholar 

  • Lewin CS, Morrissey I, Smith JT (1992) The bactericidal activity of Sparfloxacin. J Antimicrob Chemother 30:625–632

    Article  PubMed  CAS  Google Scholar 

  • Mates SM, Patel L, Karback HR, Miller MH (1983) Membrane potential in anaerobi- cally growing Staphylococcus aureus and its relationship with gentamicin uptake. Antimicrob Agents Chemother 23:526–530

    PubMed  CAS  Google Scholar 

  • Matsumoto J, Minami S (1975) Pyrido[2,3-d]pyrimidine antibacterial agents. 3. 18-alkyl- and 8-vinyl-5,8-dihydro-5-oxo-2-(l-piperazinyl)pyrido[2,3-d]pyrimidine- 6-carboxylic acids and their derivatives. J Med Chem 18:74–79

    Article  PubMed  CAS  Google Scholar 

  • Mitcher LA, Devasthale P, Zavod R (1993) Structure-activity relationships. In: Hooper DC, Wolfson JS (eds) Quinolone antimicrobial agents, 2nd edn. American Society of Microbiology, Washington, pp 3–51

    Google Scholar 

  • Morrissey I, Smith JT (1993a) Activity of quinolone antibacterials against Streptococcus pneumoniae. Drugs 45[Suppl 3]:196–197

    Article  Google Scholar 

  • Morrissey I, Smith JT (1993b) Effect of inoculum size on 4-quinolone uptake by Escherischia coli KL 16 (Abstr 19). J Pharm Pharmacol 45[Suppl 2]:1106

    Google Scholar 

  • Morrissey I, Smith JT (1994) The activity of 4-quinolones against Pseudomonas aeruginosa. Arzneimittelforschung 44:1157–1161

    Google Scholar 

  • Morrissey I, Lewin CS, Smith JT (1990) The influence of oxygen upon bactericidal potency. In: Crumplin GC (ed) The 4-quinolone antibacterial agents in vitro. Springer, Berlin Heidelberg New York, pp 23–36

    Google Scholar 

  • Ratcliffe NT, Smith JT (1983) Effects of magnesium on the activity of 4-quinolone antibacterial agents. J Pharm Pharmacol 35:61P

    Google Scholar 

  • Ratcliffe NT, Smith JT (1985a) Ciprofloxacin’s bactericidal and inhibitory actions in urine. Chemotherapia 4[Suppl 2]:385–386

    Google Scholar 

  • Ratcliffe NT, Smith JT (1985b) Norfloxacin has a novel bactericidal mechanism unrelated to that of other 4-quinolones. J Pharm Pharmacol 37[Suppl]:92P

    Article  Google Scholar 

  • Rohwedder RW, Bergan T, Thorsteinsson SB, Scholl H (1990) Transintestinal elimination of ciprofloxacin. Diagn Microbiol Infect Dis 13:127–133

    Article  PubMed  CAS  Google Scholar 

  • Ryley JF, Peters W (1970) The antimalarial activity of some quinolone esters. Ann Trop Med Parasitol 64:209–222

    PubMed  CAS  Google Scholar 

  • Sarma PS (1989) Norfloxacin a new drug in the treatment of falciparum malaria. Ann Intern Med 3:336–337

    Google Scholar 

  • Schentag JJ (1982) Aminoglycosides. In: Evans WE, Schentag JJ, Jusko WJ (eds) Applied pharmacokinetics; principles of therapeutic drug monitoring. Applied Therapeutics, San Francisco, pp 174–209

    Google Scholar 

  • Scully BE, Parry MF, Neu HC, Mandell W (1986) Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa. Lancet 2:819–822

    Article  Google Scholar 

  • Shen LL, Baranowski J, Pernet AG (1989) Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA. Biochemistry 28:3879–3885

    Article  PubMed  CAS  Google Scholar 

  • Smith JT (1984) Awakening the slumbering potential of the 4-quinolone antibacterials. Pharm J 233:299–305

    CAS  Google Scholar 

  • Smith JT (1990) Mutation rates to 4-quinolones resistance. Arzneimittelforschung 40:65–68

    PubMed  CAS  Google Scholar 

  • Smith JT (1991) Ofloxacin, a bactericidal antibacterial. Chemotherapy 37 [Suppl 1]:2–13

    Article  PubMed  CAS  Google Scholar 

  • Smith JT, Lewin CS (1988) Chemistry and mechanisms of action of the quinolone antibacterials. In: Andriole VT (ed) The quinolones. Academic, London, pp 23–82

    Google Scholar 

  • Wiedemann B, Rustige-Wiedeman C, Kratz B (1994) Comparison of the pharmacodynamic properties of quinolones (Abstr 67). 5th International Congress on New Quinolones, Singapore, p 84

    Google Scholar 

  • Zeiler H-J, Grohe K (1984) The in vitro and in vivo activity of ciprofloxacin. Eur J Clin Microbial 3:339–343

    Article  CAS  Google Scholar 

Download references

Authors
  1. J. T. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H.-J. Zeiler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Bayer AG Geschäftsbereich Pharma Pharma-Forschungszentrum, Institut für Klinische Pharmakologie, Geb. 429, D-42096, Wuppertal, Germany

    J. Kuhlmann

  2. Institut für Medizinische Mikrobiologie und Virologie, Christian-Albrechts-Universität, D-24105, Brunswiker Str. 4, Kiel, Germany

    A. Dalhoff

  3. Bayer AG Geschäftsbereich Pharma Pharma-Forschungszentrum, Institut für Chemotherapie, Geb. 405, D-42096, Wuppertal, Germany

    H.-J. Zeiler

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Smith, J.T., Zeiler, HJ. (1998). History and Introduction. In: Kuhlmann, J., Dalhoff, A., Zeiler, HJ. (eds) Quinolone Antibacterials. Handbook of Experimental Pharmacology, vol 127. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80364-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80364-2_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-80366-6

  • Online ISBN: 978-3-642-80364-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation